Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin therapy for adult females with anorexia nervosa: pilot study.The British Journal of Psychiatry · 2026-07-07Unmixing the psychedelic connectome: Brain network traits of psilocybinNetwork Neuroscience · 2026-07-01Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional surveymedRxiv · 2026-05-31Classic psychedelics and personality: An updated systematic reviewJournal of Psychopharmacology · 2026-05-30A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjectsJournal of Psychopharmacology · 2026-05-28Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake RatsNeuroscience Bulletin · 2026-05-20Demoralization in Psilocybin-Assisted Therapy for Advanced Cancer: An Exploratory Network AnalysisJournal of Pain and Symptom Management · 2026-05-11A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-13Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal HypnotherapyPreprints.org · 2026-04-06An international mega-analysis of psychedelic drug effects on brain circuit functionNature Medicine · 2026-03-31The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22Psychological support in psychedelic-assisted therapy clinical trials: A systematic reviewJournal of Psychopharmacology · 2026-03-19Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.Unknown journal · 2026-02-23Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescenceNeuropsychopharmacology · 2026-02-17Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compoundsJournal of Psychopharmacology · 2026-02-04Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybinMolecular Psychiatry · 2026-02-02Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experienceJournal of Psychopharmacology · 2026-01-25Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 StudyPsychedelic Medicine · 2025-12-22A Naturalistic Study on the Combined Neural and Psychological Effects of Psilocybin and Compassion Focused ImagerybioRxiv · 2025-12-21Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally illGeneral Hospital Psychiatry · 2025-12-09Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine.Unknown journal · 2025-12-03Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Unknown journal · 2025-11-30Unmixing the Psychedelic Connectome: Brain Network Traits of PsilocybinbioRxiv · 2025-11-16A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.Unknown journal · 2025-10-22Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.Unknown journal · 2025-10-19Neurocomputational evidence of sustained Self-Other mergence after psychedelicsmedRxiv · 2025-10-07Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia.International journal of molecular sciences · 2025-09-13Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybinMolecular Psychiatry · 2025-08-25Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trialGeneral Hospital Psychiatry · 2025-08-11Psilocybin-induced modulation of visual salience processingbioRxiv · 2025-05-11A multi-institutional investigation of psilocybin’s effects on mouse behaviorbioRxiv · 2025-04-08BIOLOGICAL ACTIVITY OF PSILOCYBIN EXTRACTS FROM THE FRUITING BODIES OF PSILOCYBE CUBENSIS ANTIOXIDANT AND ANTIMICROBIAL POTENTIALJournal of Microbiology Biotechnology and Food Sciences · 2025-03-12Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake ratsbioRxiv · 2025-02-05Music as a collaborating actor: new insights into the nature and role of music in psychedelic-assisted psychotherapy.Frontiers in psychiatry · 2024-12-31The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-05The forgotten psychedelic: Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybinbioRxiv · 2024-10-21A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-18Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.Unknown journal · 2024-07-19Psilocybin and 2C-B at Encoding Distort Episodic FamiliarityBiological Psychiatry Cognitive Neuroscience and Neuroimaging · 2024-06-25Is it now time to prepare psychiatry for a psychedelic future?The British Journal of Psychiatry · 2024-05-191. Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity and Positively Bias Emotional MetamemoryBiological Psychiatry · 2024-04-28Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.Unknown journal · 2023-12-14Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perceptionbioRxiv · 2023-10-31Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual ExperiencesReligions · 2023-10-18Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?Research Directions Depression · 2023-10-12Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.Journal of palliative medicine · 2023-09-30Perceptions of psychedelic-assisted therapy among Black AmericansJournal of Mood and Anxiety Disorders · 2023-09-25Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic BoundlessnessbioRxiv · 2023-09-17A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic aminesJournal of Biological Chemistry · 2023-09-08Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled studyBrain Behavior and Immunity · 2023-09-06Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiencesScientific Reports · 2023-08-21Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disordersbioRxiv · 2023-05-17Using Psilocybin Therapy for treating end of life distress trialThe Ballarat naturalist. · 2023-04-30The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin ExperiencebioRxiv · 2023-03-20Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020Journal of Psychopharmacology · 2023-03-05Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognitionbioRxiv · 2023-02-15Therapeutic effect of psilocybin in addiction: A systematic review.Unknown journal · 2023-02-08Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.Unknown journal · 2022-12-07Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteersmedRxiv · 2022-10-31Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31From neuroplasticity to psychoplasticity: Psilocybin may reverse personality disorders and political fanaticismCurrent Psychiatry · 2022-08-31Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.Translational Psychiatry · 2022-08-01Natural language signatures of psilocybin microdosing.Psychopharmacology · 2022-06-08Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.Expert Opinion on Drug Safety · 2022-04-26Charismatic, Synchronous and Psychedelic Religious Experiences: A Personal AccountReligions · 2022-04-06Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.Journal of Psychopharmacology · 2022-04-06Natural language signatures of psilocybin microdosingbioRxiv · 2022-02-21Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.Expert opinion on investigational drugs · 2022-01-31The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activitybioRxiv · 2021-12-06Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ Open · 2021-11-30Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in Psychiatry · 2021-10-19Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-18Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in Psychiatry · 2021-08-05Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.Frontiers in Psychiatry · 2021-06-15Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.Journal of Clinical Psychopharmacology · 2021-04-30Psilocybin: From Serendipity to Credibility?Frontiers in Psychiatry · 2021-04-20Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.Journal of Psychopharmacology · 2021-03-18The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.DOAJ (DOAJ: Directory of Open Access Journals) · 2021-03-04Psychedelic Medicines in Major Depression: Progress and Future Challenges.Unknown journal · 2020-12-31Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing?ACS chemical neuroscience · 2020-10-20Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.Unknown journal · 2020-09-04Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.Unknown journal · 2020-06-30Hallucinogens/psychedelics resurrected as new tools in psychiatric therapyBrazilian Journal of Psychiatry · 2020-05-31Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.Neuropharmacology · 2020-04-30Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.Psychopharmacology · 2019-12-31Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.Unknown journal · 2019-12-02Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frameJournal of Contextual Behavioral Science · 2019-11-04Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.Unknown journal · 2019-10-27Spectral signatures of serotonergic psychedelics and glutamatergic dissociativesNeuroImage · 2019-06-23Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.Unknown journal · 2019-04-251.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and ConsequencesJournal of the American Academy of Child & Adolescent Psychiatry · 2018-09-30Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.Unknown journal · 2018-08-22Psychedelics and Personality.ACS Chemical Neuroscience · 2018-06-03Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.Unknown journal · 2017-02-22Maddening Therapies: How Hallucinogens Morphed into Novel TreatmentsCurrent psychiatry · 2016-12-31Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.Unknown journal · 2016-10-30Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.Unknown journal · 2016-03-17The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.PLoS ONE · 2015-02-17Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiologyThe FASEB Journal · 2012-03-31Identification of a serotonin/glutamate receptor complex implicated in psychosis.Unknown journal · 2008-02-23Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.Unknown journal · 1988-12-31Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.Unknown journal · 1988-08-31Psilocin analogs II. Synthesis of 3-[2-(dialkylamino)ethyl]-, 3-[2-(N-methyl-N-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-olsJournal of Heterocyclic Chemistry · 1980-12-31Psilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl] -and 3-[2-(cycloalkylamino)ethyl] indol-4-olsJournal of Heterocyclic Chemistry · 1977-01-31The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin.Unknown journal · 1960-09-30